Ionis Pharmaceuticals
(NASDAQ) IONS
Ionis Pharmaceuticals Financials at a Glance
Market Cap
$14.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$1.06B
Net Income (TTM)
-$326.58M
EPS (TTM)
-$2.10
P/E Ratio
-41.07
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$86.31
Volume
2,735.065
Open
$84.42
Price
$86.31
Volume
2,735.065
Open
$84.42
Previous Close
$86.33
Daily Range
$82.95 - $86.67
52-Week Range
$40.03 - $86.74
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.81 (Low)
Price
$86.31
Volume
2,735.065
Open
$84.42
Previous Close
$86.33
Daily Range
$82.95 - $86.67
52-Week Range
$40.03 - $86.74
Estimated Earnings Date
Aug 5, 2026
IONS News
IONS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ionis Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
1,402
CEO
Brett P. Monia, PhD
Website
www.ionis.comHeadquarters
Carlsbad, CA 92010, US
IONS Financials
Key Financial Metrics (TTM)
Gross Margin
98.35%
Operating Margin
-33.35%
Net Income Margin
-30.87%
Return on Equity
-58.57%
Return on Capital
-12.31%
Return on Assets
-9.47%
Earnings Yield
-2.43%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$14.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
165.26M
Volume
2.74K
Avg. Volume
1.86M
Financials (TTM)
Gross Profit
$1.04B
Operating Income
-$352.79M
EBITDA
$4.59B
Operating Cash Flow
-$910.63M
Capital Expenditure
-$60.63M
Free Cash Flow
-$971.26M
Cash & ST Invst.
$1.92B
Total Debt
$2.04B
Ionis Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$246.09M
+87.0%
Gross Profit
$243.11M
+86.8%
Gross Margin
98.79%
N/A
Market Cap
$14.27BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$10.18M
N/A
Employees
1,402
N/A
Net Income
-$92.53M
+37.0%
EBITDA
-$68.52M
+42.9%
Quarterly Fundamentals
Total Cash
$1.92B
-10.5%
Total Debt
$2.04B
+4.2%
Accounts Receivable
$73.68M
+85.6%
Inventory
$5.56M
-51.7%
Long Term Debt
$1.61B
-17.4%
Short Term Debt
$432.50M
+3503.6%
Return on Assets
-9.47%
N/A
Return on Invested Capital
-12.91%
N/A
Free Cash Flow
-$814.58M
-398.7%
Operating Cash Flow
-$792.82M
-425.8%